Klinische Forschung Karlsruhe GmbH

Karlsruhe 76137

0 studies enrolling now · 6 studies all time

What they study most

Diabetes, Type 2, Gout, Gout Flare, Hyperuricemia, Influenza, Human, Insomnia Disorder, Obesity, Obesity and Overweight, Overweight, Overweight and/or Obesity, Tophi, Type 2 Diabetes

Studies at this site

• A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D) — Running, not enrolling
• Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity — Running, not enrolling
• Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients — Completed
• The Celljuvant Study: A Phase 3 Immunogenicity and Safety Study of aQIVc Vaccine in Adults Aged 50 Years and Older — Completed
• Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects With Insomnia Disorder — Completed
• Study to Assess the Long Term Safety and Tolerability of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep — Completed